Development of novel drug particles for inhalational therapy
Active Awarded Last action
- Contract number
- HT942526FE005
- Awardee
-
Crititech Particle Engineering Solutions, LLC UEI QMLLX81RZ6V9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $140,595
Award facts
- Contract value 100% obligated
- $140,595.49 Current and potential, with all options
- Completion date 88% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Lawrence, KS 66044, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $140.6K firm fixed-price delivery order to Crititech Particle Engineering Solutions, LLC for the development of novel drug particles for inhalational therapy. The work will be performed at Crititech's facility in Lawrence, Kansas, with an ultimate completion date of December 2, 2026. This delivery order was issued without a small business set-aside designation, indicating open competition contracting. Crititech, a for-profit limited liability company specializing in pharmaceutical particle engineering, maintains an active federal registration and is well-positioned to support the Defense Health Agency's medical and healthcare innovation objectives.
This delivery order is issued under Crititech's single-award Indefinite Delivery Contract with the Defense Health Agency, which was established on September 9, 2024, with a ceiling value of $709,995.75 and a performance period extending through September 8, 2029. The IDC structure demonstrates the Defense Health Agency's confidence in Crititech's specialized capabilities and its commitment to maintaining an ongoing partnership for pharmaceutical particle engineering services. This is the third delivery order issued under the parent contract, reflecting the agency's sustained need for novel drug particle development to support Defense medical innovation initiatives.
Quick answers
Who was awarded contract HT942526FE005?
HT942526FE005 was awarded to Crititech Particle Engineering Solutions, LLC by Defense Health Agency (Department of Defense) on December 3, 2025.
How much is contract HT942526FE005 worth?
The government has obligated $140,595 on HT942526FE005.
Is contract HT942526FE005 an order under another contract?
Yes. HT942526FE005 is a delivery order under HT942524D0011, an indefinite delivery contract.
Was contract HT942526FE005 competed?
The extent of competition for HT942526FE005 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award